"Drug Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
| Descriptor ID |
D004351
|
| MeSH Number(s) |
G07.690.773.984
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance".
This graph shows the total number of publications written about "Drug Resistance" by people in this website by year, and whether "Drug Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 2 | 3 | 5 |
| 2014 | 0 | 3 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 4 | 4 |
| 2017 | 33 | 52 | 85 |
| 2018 | 20 | 38 | 58 |
| 2019 | 4 | 14 | 18 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Resistance" by people in Profiles.
-
Coronavirus disease 2019 (COVID-19) in a pregnant women with treatment resistance thrombocytopenic purpura with and suspicion to HELLP syndrome: a case report. BMC Pregnancy Childbirth. 2021 Aug 18; 21(1):567.
-
COVID-19 and malaria, a tale of two diseases. EBioMedicine. 2021 Aug; 70:103554.
-
SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing DUSP1 expression and activating p38 MAPK pathway. Eur J Pharmacol. 2021 Oct 05; 908:174374.
-
HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region. Braz J Infect Dis. 2021 May-Jun; 25(3):101596.
-
Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit. Int J Lab Hematol. 2021 Dec; 43(6):1284-1290.
-
Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries. J Trop Pediatr. 2021 01 29; 67(1).
-
Nanotechnology in pulmonary medicine. Curr Opin Pharmacol. 2021 02; 56:85-92.
-
Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens. Paediatr Int Child Health. 2021 02; 41(1):65-75.
-
Differentiating biochemical from clinical heparin resistance in COVID-19. J Thromb Thrombolysis. 2020 11; 50(4):1015-1016.
-
Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients. J Thromb Haemost. 2020 Nov; 18(11):3109-3110.